Legend Biotech to Host R&D Day on October 18, 2021
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Business Wire
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, will host its first Research & Development Day on Monday, October 18, commencing at 10:00 a.m. (Eastern Time), at Andaz 5th Avenue in New York.The meeting will feature updates on the company’s advancing pipeline of hematological and oncological indications and expanding cell therapy capabilities, including its B cell maturation antigen (BCMA) clinical development program. Presentations will be delivered by Legend’s senior leadership team:Ying Huang, PhD, Chief Executive Officer and Chief Financial OfficerFrank Fan, MD, PhD, Chief Scientific OfficerSteve Gavel, Vice President, US & Europe CommercialLida Pacaud, MD, Vice President, Clinical DevelopmentA live webcast and presentation will be available to investors and other interested parties on the Legend Biot
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy [Seeking Alpha]Seeking Alpha
- Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report [Yahoo! Finance]Yahoo! Finance
- Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) ReportBusiness Wire
- Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.MarketBeat
- Legend Biotech Co. (NASDAQ: LEGN) had its price target raised by analysts at UBS Group AG from $76.00 to $81.00. They now have a "buy" rating on the stock.MarketBeat
LEGN
Sec Filings
- 3/27/24 - Form 144
- 3/26/24 - Form 144
- 3/25/24 - Form 144
- LEGN's page on the SEC website